Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.068 | 0.7 |